Any Western New Yorker who tests positive for COVID-19 almost certainly has contracted the delta variant, University at Buffalo scientists reported today.
Study's findings have broad implications when thinking about the challenges associated with autism, including difficulties when interacting with others and making social connections.
The UB program offers students a unique opportunity to engage in research and training to combat disease, as well as help develop a pipeline of research leaders focused on therapeutic individualization and optimization of patient care.
Using a new class of drugs developed at UB, researchers aim to prevent anticancer toxins from harming healthy tissue. The work is supported by a $1.8 million grant from the National Cancer Institute.
The research found that photobiomodulation – a form of low-dose light therapy – sped up recovery from burns and reduced inflammation in mice by activating endogenous TGF‐beta 1, a protein that controls cell growth and division.